NDC 57926-464 - Salix
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 57926-464
- Package NDCs from labels
- 57926-464-31
- Manufacturer
- Merck Sharp & Dohme Corp.
- Effective date
- 2025-10-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Salix ® (furosemide tablets) | Merck Sharp & Dohme Corp. | 2025-10-30 | PRESCRIPTION ANIMAL DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 57926-464-31 | Salix | 500 in 1 BOTTLE | TABLET | 500 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Furosemide | ACTIVE INGREDIENT | 7LXU5N7ZO5 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Furosemide | ACTIVE MOIETY | 7LXU5N7ZO5 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Cellulose, Microcrystalline | INACTIVE INGREDIENT | OP1R32D61U | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| FD&C Yellow No. 5 | INACTIVE INGREDIENT | I753WB2F1M | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Lactose Monohydrate | INACTIVE INGREDIENT | EWQ57Q8I5X | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Magnesium Stearate | INACTIVE INGREDIENT | 70097M6I30 | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 | |
| Starch, Corn | INACTIVE INGREDIENT | O8232NY3SJ | SALIX (FUROSEMIDE) TABLET [SCHERING CORPORATION] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 25171259-dcf1-4984-9581-cd69dee8dffb | 2023-04-19 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Calvin Scott & Co., Inc. | 43be0231-0d88-4a21-b2ab-793155cbddb2 | 2023-03-23 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 01a5f094-b473-4e46-9e61-69d5ec6dd766 | 2023-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 6820724c-1ca5-451c-9d2b-2d38e60036f5 | 2023-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 440aaaed-47df-4bb5-8b41-2c8056893679 | 2023-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 15ae6f44-88dd-4455-b1f7-4718c91e7b66 | 2023-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Bryant Ranch Prepack | 3ad12e70-3c2e-44af-bb6b-5762d181c76b | 2023-03-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | A-S Medication Solutions | 52f0c9d5-396f-4033-abe8-145eec3e6983 | 2023-02-06 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Lifestar Pharma LLC | 92f3ab5d-361c-4e12-bb50-fd4a9f195a8f | 2022-12-22 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Proficient Rx LP | 595ddaf2-c2cb-44a4-a46c-53bcfe6bd752 | 2022-12-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Sagent Pharmaceuticals | d63c1277-dd7e-4d21-9e80-68143f55e2dc | 2022-11-29 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Leading Pharma, LLC | b5c6fcf4-fd37-4fee-8dac-1a3273d95ffe | 2022-11-11 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Precision Dose Inc. | 4a746634-379b-4847-a965-7607d2a71bed | 2022-09-21 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 6f124d7d-a19d-4de6-8ea4-719a42eb520b | 2022-03-10 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| FUROSEMIDE | FUROSEMIDE | HF Acquisition Co LLC, DBA HealthFirst | c5d9b063-e3fe-ec2f-e053-2995a90ab3f2 | 2021-06-28 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Proficient Rx LP | ce84359c-2f76-421a-9b2b-79b1c2be2f20 | 2021-01-01 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Gland Pharma Limited | 644704c0-e6a5-4804-bfa6-795c8f83aa7a | 2020-07-03 | Boxed warning, Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 1d2733ac-6fa6-44d1-96d4-f1a698045ad2 | 2018-04-18 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
| Furosemide | FUROSEMIDE | Aphena Pharma Solutions - Tennessee, LLC | 6fbf7f3d-7566-44d5-9507-c4460238fc91 | 2018-02-09 | Warnings, Adverse reactions | 7LXU5N7ZO5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.